The UK Inflammatory Bowel Disease (IBD) audit programme began in 2006 and is the first truly national audit performed within gastroenterology.
The UK IBD audit programme aims to improve the quality and safety of care for people with IBD throughout the UK by assessing individual patient care and the provision and organisation of IBD service resources.
Between March 2016 and February 2017, the IBD programme aims to assist the transition of data collection for IBD over to the IBD Registry. More information about this – including geographical coverage, methodology, timings and key documentation – is available on the IBD Registry website.
This programme is commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England & Wales, as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP). Additional funding has also been received from Healthcare Improvement Scotland (HIS).
The work of the IBD programme is directed by the transition steering group and is clinically led by Dr Ian Arnott, consultant gastroenterologist at NHS Lothian, and Dr Ian Shaw, consultant gastroenterologist at Gloucestershire Hospitals NHS Foundation Trust.
Over 90% of trusts and health boards in the UK participate in the IBD programme.
The IBD programme is guided by the multidisciplinary IBD programme steering group, which is a collaborative partnership between gastroenterologists (the British Society of Gastroenterology), colorectal surgeons (the Association of Coloproctology of Great Britain and Ireland), patients (Crohn's and Colitis UK), physicians (the Royal College of Physicians), nurses (the Royal College of Nursing), pharmacists (the Royal Pharmaceutical Society), dietitians (the British Dietetic Association) and paediatric gastroenterologists (the British Society of Paediatric Gastroenterology, Hepatology and Nutrition).